HomeCompareCLDL vs JNJ

CLDL vs JNJ: Dividend Comparison 2026

CLDL yields 0.21% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 JNJ wins by $60.00 in total portfolio value· pulled ahead in Year 10
10 years
CLDL
CLDL
● Live price
0.21%
Share price
$14.14
Annual div
$0.03
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$21.14
Full CLDL calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — CLDL vs JNJ

📍 JNJ pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCLDLJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CLDL + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CLDL pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLDL
Annual income on $10K today (after 15% tax)
$17.72/yr
After 10yr DRIP, annual income (after tax)
$17.97/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $685.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLDL + JNJ for your $10,000?

CLDL: 50%JNJ: 50%
100% JNJ50/50100% CLDL
Portfolio after 10yr
$20.0K
Annual income
$424.46/yr
Blended yield
2.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CLDL
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLDL buys
0
JNJ buys
0
No recent congressional trades found for CLDL or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCLDLJNJ
Forward yield0.21%3.36%
Annual dividend / share$0.03$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$20.0K$20.0K
Annual income after 10y$21.14$827.78
Total dividends collected$210.00$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CLDL vs JNJ ($10,000, DRIP)

YearCLDL PortfolioCLDL Income/yrJNJ PortfolioJNJ Income/yrGap
1$10,721$20.85$10,676$355.77+$45.00CLDL
2$11,492$20.89$11,407$389.39+$85.00CLDL
3$12,318$20.93$12,198$426.53+$120.00CLDL
4$13,201$20.97$13,056$467.62+$145.00CLDL
5$14,146$21.00$13,987$513.12+$159.00CLDL
6$15,157$21.03$14,998$563.56+$159.00CLDL
7$16,239$21.06$16,098$619.52+$141.00CLDL
8$17,397$21.09$17,295$681.69+$102.00CLDL
9$18,636$21.11$18,599$750.82+$37.00CLDL
10← crossover$19,962$21.14$20,022$827.78$60.00JNJ

CLDL vs JNJ: Complete Analysis 2026

CLDLStock

The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is provided by Indxx, LLC and includes domestic companies that deliver cloud computing infrastructure, platforms, or services. The fund is non-diversified.

Full CLDL Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this CLDL vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLDL vs SCHDCLDL vs JEPICLDL vs OCLDL vs KOCLDL vs MAINCLDL vs ABBVCLDL vs MRKCLDL vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.